Czechia – Immunosuppressive agents – Dodávky léků – Léčivá látka infliximab k subkutánnímu podání – ATC L04AB02

The subject of the Public Contract is the continuous supply of a medicinal product containing the active substance infliximab for subcutaneous administration – ATC L04AB02. LL - infliximab for subcutaneous administration, dosage form 120MG INJ SOL PEP, unit of measurement 2X1ML LL - infliximab for subcutaneous administration, dosage form 120MG INJ SOL ISP, unit of measurement 2X1ML quantity 4000